ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-CD64 Antibody [UMAB74] - BSA and Azide free (A321649)

Mouse monoclonal [UMAB74] antibody to CD64 for ChIP, Flow Cytometry, IHC and WB.

Alternative Formats and ConjugatesAlternative Formats

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 6-9 business days.
Name
Anti-CD64 Antibody [UMAB74] - BSA and Azide free
Description
Mouse monoclonal [UMAB74] antibody to CD64.
Applications
ChIP, Flow Cytometry, IHC, WB
Dilutions
IHC: 1:100
Reactivity
Human
Immunogen
Recombinant full-length human CD64 (NP_000557), expressed in and purified from HEK293T cells.
Host
Mouse
Clonality
Monoclonal
Clone ID
UMAB74
Isotype
IgG1
Conjugate

Unconjugated

Purification
Protein A/G affinity chromatography.
Concentration
Reconstitution dependent.
Predicted MW
42.5 kDa
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl distilled water.
Formulation
Lyophilized from Phosphate Buffered Saline, pH 7.3, with 8% Trehalose.
Storage
Shipped at 4°C. Store at -20°C. Avoid freeze/thaw cycles.
General Notes
To guarantee optimal conjugation, we recommend performing another round of desalting for all carrier-free antibodies.
Synonyms
Fc gamma receptor IB pseudogene, Fc-gamma RI, Fc-gamma RIA, Fc-gamma RIB, FCG1, FcgammaRIa, FCGR1, FCGR1A, FCGR1B, FCGR1BP, FcRI, FcRIB, hFcgammaRIB, High affinity immunoglobulin gamma Fc receptor I, IGFR1, IGFRB, IgG Fc receptor I, IgG Fc receptor IB, Putative high affinity immunoglobulin gamma Fc receptor IB
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Anti-CD64 Antibody [UMAB74] - BSA and Azide free (A321649)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-CD64 Antibody [UMAB74] - BSA and Azide free (A321649)

Proteins predicted to interact with CD64

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
98.9% Relevancy Score
98.7% Relevancy Score
98.6% Relevancy Score
98.5% Relevancy Score
96% Relevancy Score
94.9% Relevancy Score
94.3% Relevancy Score
93.9% Relevancy Score
92.1% Relevancy Score